{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:43:51Z","timestamp":1777319031011,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bone.2024.117045","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T12:17:12Z","timestamp":1707394632000},"page":"117045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Sustained hypophosphatemia after denosumab in a patient on hemodialysis"],"prefix":"10.1016","volume":"181","author":[{"given":"Ahmed A.S.","family":"Almodares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grahame J.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bone.2024.117045_bb0005","first-page":"604","article-title":"Technology evaluation: denosumab, Amgen","volume":"7","author":"Abrahamsen","year":"2005","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"10","key":"10.1016\/j.bone.2024.117045_bb0010","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","article-title":"Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies","volume":"25","author":"Reid","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2024.117045_bb0015","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term Denosumab on bone Histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2024.117045_bb0020","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: a cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bone.2024.117045_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000380960","article-title":"Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5","volume":"41","author":"Dave","year":"2015","journal-title":"Am. J. Nephrol."},{"issue":"1 Suppl","key":"10.1016\/j.bone.2024.117045_bb0030","article-title":"Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial","volume":"189","author":"Fizazi","year":"2013","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.bone.2024.117045_bb0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2011.04.001","article-title":"Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys","volume":"49","author":"Ominsky","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2024.117045_bb0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000339818","article-title":"Phosphate enrichment of dialysate for use in standard and extended haemodialysis","volume":"34","author":"Ebah","year":"2012","journal-title":"Blood Purif."},{"issue":"3","key":"10.1016\/j.bone.2024.117045_bb0045","first-page":"311","article-title":"Calcium and phosphorus deficiencies in patients with liver cirrhosis","volume":"48","author":"Ionele","year":"2022","journal-title":"Curr. Health Sci. J."},{"issue":"4","key":"10.1016\/j.bone.2024.117045_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13041249","article-title":"Micronutrient deficiencies in patients with decompensated liver cirrhosis","volume":"13","author":"Llibre-Nieto","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.bone.2024.117045_bb0055","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jbmr.4558","article-title":"Osteomalacia as a complication of intravenous Iron infusion: a systematic review of case reports","volume":"37","author":"Vilaca","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2024.117045_bb0060","first-page":"154","article-title":"Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management","author":"Schaefer","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117045_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S243462","article-title":"Hypophosphatemia associated with intravenous Iron therapies for Iron deficiency Anemia: a systematic literature review","volume":"16","author":"Glaspy","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"issue":"2","key":"10.1016\/j.bone.2024.117045_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1744-9987.2011.01037.x","article-title":"Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patients","volume":"16","author":"Hryszko","year":"2012","journal-title":"Ther. Apher. Dial."},{"issue":"5","key":"10.1016\/j.bone.2024.117045_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000327019","article-title":"Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients","volume":"33","author":"Takeda","year":"2011","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2024.117045_bb0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12185-022-03401-0","article-title":"Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study","volume":"116","author":"Kawabata","year":"2022","journal-title":"Int. J. Hematol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:24:26Z","timestamp":1754493866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328224000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":16,"alternative-id":["S8756328224000346"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2024.117045","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained hypophosphatemia after denosumab in a patient on hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2024.117045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117045"}}